Full article view2017-09-21T08:01:31+00:00

POLITICO Pulses on Launch of IVI's New Open-Source Value Tool


Must-read morning briefing POLITICO Pulse talks with Innovation & Value Initiative (IVI) executive director Darius Lakdawalla on the launch of a first-of-its-kind open-source project for determining the value of medical treatments. IVI, a Precision Health Economics-backed collaboration, is debuting the tool for use in rheumatoid arthritis. “There is nothing worse than cutting valuable dollars and letting wasteful spending multiply,” Lakdawalla says.

To read the item, click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.